LAST CHANCE TO SAVE! New Trends for Life Sciences at PACK EXPO Southeast
Discover all the latest packaging solutions for life sciences products at the all-new PACK EXPO Southeast in Atlanta, GA, March 10-12, 2025
REGISTER ASAP FOR $30!

Packaging helps ACell deliver regenerative products

Its next-generation MatriStem products for wound care and soft tissue repair are packaged on multiple lines with shelf life ranging from six months to two years.

Packaging helps ACell deliver regenerative products.
Packaging helps ACell deliver regenerative products.

Arguably one of the most exciting and promising areas of medical treatment is that of regenerative medicine. In fact, last March, a finance.yahoo.com article cited TriMark Publications with publishing a report forecasting that the regenerative medicine market will “catapult to over $35 billion by 2019.”

The article categorizes regenerative medicine into tissue engineering, biomaterials, and biomolecules, e.g., scaffolds, growth factors, and stem cell therapy. ACell, Inc. is a Columbia, MD-based developer, manufacturer, and marketer of “next-generation regenerative products,” according to the company’s website. “Our medical devices are cleared for a variety of indications and are marketed under the brand name ‘MatriStem.” These products are produced at the company’s manufacturing sites in Columbia and Lafayette, IN, marketed through a direct sales force to physicians in the U.S.

“Our products are based on our proprietary urinary bladder matrix, or UBM, technology platform,” explains Rodney Bosley, ACell’s President. He explains, “Regenerative medicine is an interdisciplinary field that combines the technologies of biology, engineering, and traditional medicine to develop strategies to repair or replace diseased or injured tissues and organs.”

Bosley offers the following background details on the subject: “When not responsive to the standard of care, complex wounds and surgical soft tissue repair can lead to a variety of adverse reactions, including scarring and infection. Synthetic wound and surgical products were initially developed to help the body heal itself through scarring. Even with the development of synthetic products, complex wounds and surgical soft tissue repair remained difficult to manage, which led to the development and introduction of ECM-derived scaffolds.”

He says there are various ECM-derived scaffolds available, including products “using different tissue sources and processing techniques that may limit the constructive remodeling of the body. These existing regenerative medicine products generally consist of a scaffold with or without cells or other proteins,” he notes. “Our MatriStem products address the limitations of existing regenerative medicine products and are often used to manage complex wounds or surgical soft tissue repairs where the standard of care and existing competitive regenerative therapy treatments have not been effective.

LAST CHANCE TO SAVE! New Tech for Life Sciences at PACK EXPO Southeast
The exciting new PACK EXPO Southeast 2025 unites all vertical markets in one dynamic hub, generating more innovative answers to packaging challenges for life sciences products. Don’t miss this extraordinary opportunity for your business!
REGISTER ASAP FOR $30!
LAST CHANCE TO SAVE! New Tech for Life Sciences at PACK EXPO Southeast